ERBB2 and breast carcinoma: ERBB2 amplification and protein overexpression play variable roles in diverse cancers such as breast cancer (BC), esophagogastric and gastric cancer (GC), ovarian cancer, UBC, extrahepatic cholangiocarcinoma, lung cancer, and colon cancer [11,12,13].